Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Lion

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Oncotarget|July 3, 2018
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approachesMaarten Versteven, Johan M J Van den Bergh, Katrijn Broos, et al.
Oncotarget|September 17, 2017
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cellsJonas R M Van Audenaerde, Jorrit De Waele, Elly Marcq, et al.
Elife|January 25, 2022
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccinationGeorge Elias, Pieter Meysman, Esther Bartholomeus, et al.
Bone Marrow Transplantation|June 13, 2020
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivityDiede van Ens, Charlotte M Mousset, Tim J A Hutten, et al.
Frontiers in Immunology|August 13, 2021
Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And FluoroquinolonesJessy Elst, Marcus Maurer, Vito Sabato, et al.
Frontiers in Immunology|June 5, 2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccineLucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Cancer Immunology, Immunotherapy : CII|April 13, 2015
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functionsYannick Willemen, Johan M J Van den Bergh, Eva Lion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerYana Debie, Jonas R M Van Audenaerde, Timon Vandamme, et al.
Immunogenetics|December 3, 2017
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinityPieter Meysman, Nicolas De Neuter, Esther Bartholomeus, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Oncotarget|July 3, 2018
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approachesMaarten Versteven, Johan M J Van den Bergh, Katrijn Broos, et al.
Oncotarget|September 17, 2017
Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cellsJonas R M Van Audenaerde, Jorrit De Waele, Elly Marcq, et al.
Elife|January 25, 2022
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccinationGeorge Elias, Pieter Meysman, Esther Bartholomeus, et al.
Bone Marrow Transplantation|June 13, 2020
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivityDiede van Ens, Charlotte M Mousset, Tim J A Hutten, et al.
Frontiers in Immunology|August 13, 2021
Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And FluoroquinolonesJessy Elst, Marcus Maurer, Vito Sabato, et al.
Frontiers in Immunology|June 5, 2026
CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccineLucia Mazzotti, Gerardo Musuraca, Fabio Affaticati, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Cancer Immunology, Immunotherapy : CII|April 13, 2015
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functionsYannick Willemen, Johan M J Van den Bergh, Eva Lion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerYana Debie, Jonas R M Van Audenaerde, Timon Vandamme, et al.
Immunogenetics|December 3, 2017
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinityPieter Meysman, Nicolas De Neuter, Esther Bartholomeus, et al.
Pageof 7